AU2001261324A1 - Psoriasis treatment - Google Patents
Psoriasis treatmentInfo
- Publication number
- AU2001261324A1 AU2001261324A1 AU2001261324A AU6132401A AU2001261324A1 AU 2001261324 A1 AU2001261324 A1 AU 2001261324A1 AU 2001261324 A AU2001261324 A AU 2001261324A AU 6132401 A AU6132401 A AU 6132401A AU 2001261324 A1 AU2001261324 A1 AU 2001261324A1
- Authority
- AU
- Australia
- Prior art keywords
- psoriasis treatment
- psoriasis
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 201000004681 Psoriasis Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Environmental Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56657400A | 2000-05-08 | 2000-05-08 | |
US09566574 | 2000-05-08 | ||
PCT/US2001/014988 WO2001085151A2 (en) | 2000-05-08 | 2001-05-08 | Chimeric animal model and treatment of psoriasis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001261324A1 true AU2001261324A1 (en) | 2001-11-20 |
Family
ID=24263461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001261324A Abandoned AU2001261324A1 (en) | 2000-05-08 | 2001-05-08 | Psoriasis treatment |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001261324A1 (en) |
WO (1) | WO2001085151A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004101072A1 (en) * | 2003-05-16 | 2004-11-25 | Universite Laval | Cns chloride modulation and uses thereof |
EP1653972A1 (en) * | 2003-07-23 | 2006-05-10 | Creabilis Therapeutics s.r.l. | Topical use of tyrosine kinase inhibitors of microbial origin to prevent and treat skin disorders characterised by excessive cell proliferation |
WO2005110490A1 (en) | 2004-05-14 | 2005-11-24 | Universite Laval | Phospholipase c gamma modulation and uses thereof for management of pain and nociception |
DK1919979T4 (en) * | 2005-08-25 | 2017-07-17 | Creabilis Therapeutics Spa | Polymer conjugates of K-252A and derivatives thereof |
ES2352929B1 (en) * | 2009-08-14 | 2012-01-26 | Centro De Investigaciones Energeticas. Medioamb Ientales Y Tecnologicas (Ciemat) | HUMANIZED PSORIASIS MODEL |
FR3045385B1 (en) * | 2015-12-22 | 2019-12-20 | Jean-Noel Thorel | COSMETIC COMPOSITION COMPRISING NERVE GROWTH FACTOR EXPRESSION INHIBITORS FOR THE TREATMENT OF PSORIASIS, ATOPIC DERMATITIS AND PRURITUS |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5945576A (en) * | 1996-04-05 | 1999-08-31 | Brigham & Women's Hospital, Inc. | Mouse model of psoriasis |
ES2184106T3 (en) * | 1996-06-25 | 2003-04-01 | Cephalon Inc | USE OF THE K-252A DERIVATIVE IN THE TREATMENT OF THE PERIPHERAL OR CENTRAL NERVOUS SYSTEM, AND THE HYPERPRODUCTION OF CYTOKINES. |
WO1998044908A1 (en) * | 1997-04-07 | 1998-10-15 | The Board Of Trustees Of The Leland Stanford Junior University | Method of regulating epithelial growth |
US6013646A (en) * | 1998-07-02 | 2000-01-11 | Bayer Corporation | Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer |
IT1302264B1 (en) * | 1998-09-24 | 2000-09-05 | Innovet Italia Srl | DERIVATIVES WITH N-ACYL VANILLYAMIDE STRUCTURE ABLE TO ACTIVATE PERIPHERAL IRECEPTORS OF CANNABINOIDS |
-
2001
- 2001-05-08 AU AU2001261324A patent/AU2001261324A1/en not_active Abandoned
- 2001-05-08 WO PCT/US2001/014988 patent/WO2001085151A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001085151A3 (en) | 2002-05-23 |
WO2001085151A2 (en) | 2001-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002223827A1 (en) | Well treatment | |
AU2001260513A1 (en) | Microcapsule well treatment | |
AU2002215125A1 (en) | Well treatment method | |
AU2002222853A1 (en) | Therapeutic compounds | |
AU2002342613A1 (en) | Treatment for wounds | |
AU5089400A (en) | Arthritis treatment | |
AU2001239858A1 (en) | Wastewater treatment process | |
AU2002324201A1 (en) | Waste treatment | |
AU2001226910A1 (en) | Electrolytic treatment | |
AU2002319286A1 (en) | Skin treatment | |
AU5547000A (en) | Novel treatment | |
AU2002227925A1 (en) | Human beta-defensin-3 | |
AU4556800A (en) | Novel treatment | |
AU2001236929A1 (en) | Surface treatment | |
AU2002335667A1 (en) | Modified reoviral therapy | |
AU2001261324A1 (en) | Psoriasis treatment | |
AU2001294183A1 (en) | Waste treatment equipment | |
AU2002210297A1 (en) | Water treatment assembly | |
AU2001257325A1 (en) | Cancer treatment | |
AU2001289127A1 (en) | Tumor treatment | |
AU2001292897A1 (en) | Novel therapy | |
AU2001253560A1 (en) | Methods of treatment | |
AU2001257168A1 (en) | Cancer treatment | |
AU2001271537A1 (en) | Cough treatment | |
AUPR814901A0 (en) | Water treatment |